Clinical Trial Results. org C. Michael Gibson, M.S., M.D. Director TIMI Data Coordinating Center Invasive Cardiologist Beth Israel Deaconess Medical Center.

Slides:



Advertisements
Similar presentations
Early Impaired Myocardial Perfusion is Associated with Larger SPECT Infarct Size Patients with a closed myocardium (TMPG 0/1) and patients without complete.
Advertisements

Protection Devices in PCI-Treatment of Myocardial Infarction for Salvage of Endangered Myocardium Study Presented at American College of Cardiology Scientific.
FFR & IVUS PRIOR TO REVASCULARISATION Journal review Dr. Sony Manuel M Senior Resident MCH Kozhikode.
FFR & IVUS PRIOR TO REVASCULARISATION Journal review Dr.Sony Manuel M Senior Resident MCH Kozhikode.
Unstable Angina: Embolism Can Occur Prior to PCI Thrombus in proximal RCA Stain of muscle before injection begins: TIMI Myocardial perfusion grade 1 CM.
ISCHAEMIC HEART DISEASE Acute Coronary Syndromes JD Marx Department of Cardiology University of the Free State.
A Risk Score for Predicting Coronary Artery Bypass Surgery in Patients with Non-ST Elevation Acute Coronary Syndromes Sai Sadanandan, MD*; Christopher.
Intracoronary Serotonin and Endothelin Release After PCI / Stenting Taylor AJ. Am Heart J Aug;148(2): e10 Leosco et al, AJC 1999;84:
University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.
GUSTO I GUSTO I Median Time (hrs) Between Symptom Onset and Treatment GUSTO III GUSTO III InTIME II InTIME II ASSENT.
Francesco Liistro Cardiovascular Department, Arezzo, Italy Impact of Thrombus Aspiration on Myocardial Tissue Reperfusion and Left Ventricular Functional.
Results of CRYSTAL AMI: A Pilot Trial Before INFUSE AMI, the Concept and Evolution in Thrombus Management Saihari Sadanandan, MD, FACC, FASE, Dip. CBNC,
GP IIb/IIIa Inhibition in STEMI: Growing Clinical Trial Evidence.
Murat Sezer, Emre Aslanger, Arif Cimen, Ebru Yormaz, Cuneyt Turkmen, Berrin Umman, Yılmaz Nisanci, Zehra Bugra and Sabahattin Umman Istanbul University,
Is PCI necessary for AMI related artery with TIMI 3 flow ? Donghoon Choi Yonsei Cardiovascular Center Yonsei University College of Medicine.
TITAN Time to Integrilin Therapy in Acute myocardial infarctioN (TITAN)-TIMI 34.
Published in Circulation 2003 Rory Hachamovitch, MD, MSc; Sean W. Hayes, MD; John D. Friedman, MD; Ishac Cohen PhD; Daniel S. Berman, MD Comparison of.
Improving outcome of STEMI PCI: Preliminary Results of Crystal AMI trial Rajesh M. Dave, MD Principal investigator on behalf of Crystal AMI Investigators.
The index of microvascular resistance measured acutely predicts infarct severity and left ventricular function at 3 months in patients with ST segment.
Beyond TIMI 3 Flow CTFC < 14 CTFC > % (n=41) (n = 18/640) (n =35/563) 2.8% p= “TIMI 4” Flow TIMI 3 Flow 14 < CTFC < % % Risk of In Hospital.
Intracoronary Streptokinase after Primary PCI Sezer M et al., NEJM May 3 rd 2007.
TIMI 14 Antman et al. Circ 99: 2720,1999 Phases of Trial ControlInvestigational Accel tPA Accel tPA Accel tPA rPA ( U) rPA ( U) No lytic Abx.
The 90 Minute Wall: 60% Rates of TIMI Grade 3 Flow % TIMI 3 Flow.
UNIVERSITÄT LEIPZIG H E R Z Z E N T R U M Infarct transmurality and infarct size assessed by delayed enhancement magnetic resonance imaging: Association.
Effect of Distal Embolisation on Myocardial Perfusion Reserve Following Percutaneous Coronary Intervention: A Quantitative MR Perfusion Study Selvanayagam.
Relationship of Ultrasound Plaque Characteristics to TMPG Following Intracoronary Stenting ↓ TMPG Post PCINo Δ or ↑ TMPGp-value Pre-PCI Plaque Area12.4.
Proof of Concept #1: Occluded Arteries Cause Acute MI Proof of Concept #1: Occluded Arteries Cause Acute MI Proof of Concept #2: Drugs (in this case IC.
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
Late Open Artery Hypothesis Jason S. Finkelstein, M.D. Tulane University Medical Center 2/24/03.
PROTECT: What Have We Learned Lesson 2: TMPG is associated with clinical and biomarker outcomes following PCI.
Randomized Trial to Evaluate the Relative PROTECTion against Post-PCI Microvascular Dysfunction and Post-PCI Ischemia among Anti-Platelet and Anti-Thrombotic.
The MASTER Trial A Prospective, Randomized, Multicenter Evaluation of a PET Micronet Mesh Covered Stent (MGuard) in STEMI Sigmund Silber, MD, PhD FESC,
Francone M, Bucciarelli-Ducci C*, Carbone I, Canali E, Scardala R, Calabrese F, Sardella G, Mancone M, Catalano C, Fedele F, Passariello R, Bogaert J**
Randomized Early versus Late AbciXimab in Acute Myocardial Infarction treated with primary coronary intervention (RELAx-AMI Trial) Mauro Maioli M.D., Francesco.
Effect of Thrombus Aspiration in Patients With Myocardial Infarction Presenting Late After Symptom Onset Steffen Desch, MD Thomas Stiermaier, MD; Suzanne.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Value of Platelet Reactivity in Predicting Response.
Relationship of the TIMI Myocardial Perfusion Grades, Flow Grades, Frame Count, and Percutaneous Coronary Intervention to Long-Term Outcomes After Thrombolytic.
M-Guard stent in STEMI patients with high thrombus burden lesions Mahmoud Shabestari Baktash Bayani Ali Eshraghi Bahram Shahri Mashhad University.
Rationale for TOTAL trial: randomized trial of routine aspiration ThrOmbecTomy with PCI vs. PCI ALone in patients with STEMI undergoing primary PCI Sanjit.
Total Occlusion Study of Canada (TOSCA-2) Trial
Use of fractional flow reserve in patients with coronary artery disease: The right choice for the right outcome  Jae Yoon Park, MD, Amir Lerman, MD, Joerg.
Intra Coronary AdjunctivE Tenecteplase During Primary PCI for STEMI:
Presenter Disclosure Information
TITAN Time to Integrilin Therapy in Acute myocardial infarctioN (TITAN)-TIMI 34 Dr. Eugene Braunwald was the study chairman and Ms. Carolyn McCabe the.
No Reflow Reflow P value Arrhythmia 40% 18% Lecture Notes
Dr Heerajnarain Bulluck Research fellow
ATLANTIC Trial design: Participants with STEMI being transported for primary PCI were randomized in the ambulance to ticagrelor 180 mg (n = 909) vs. placebo.
Alexander Liu et al. JACC 2018;71:
PROTECT – TIMI 30 Trial Randomized Trial to Evaluate the Relative PROTECTion against Post-PCI Microvascular Dysfunction and Post-PCI Ischemia among Anti-Platelet.
Published in the European Heart Journal
In STEMI Complete Reperfusion (TFG 3, TMPG 3, ST Res  70%) is Associated with a Greater Percent of Receptors Occupied by Integrilin 52.0% % Pts With Complete.
Myocardial Staining (TMPG 1)  Post-Stent in AMI
Significance of Periprocedural Myocardial Infarctions in Percutaneous Coronary Interventions A New Look at an Old Topic Abhiram Prasad, MD, FRCP, FESC,
52.0% Complete Resolution TFG 3 TMPG 3 ST Resolution  70% p=0.006
PROTECT: What Have We Learned
Antithrombin Therapy in the Management of ACS
TIMI Myocardial Perfusion (TMP) Grades Dye strongly persistent
Dye strongly persistent
Expanding the Recognition and Assessment of Bleeding Events Associated With Antiplatelet Therapy in Primary Care  Marc Cohen, MD  Mayo Clinic Proceedings 
Welcome Ask The Experts March 24-27, 2007 New Orleans, LA.
A New Angiographic Risk Score in Facilitated PCI
Dye strongly persistent
Association of Troponin Elevation with Risk of Mortality in Acute Coronary Syndromes Mortality at 42 Days  % A study by Antman and.
European Heart Journal Advance Access
MRI Hyperenhancement is Associated with Myonecrosis Following PCI
Evolution of Myocardial Blush after MI
A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.
GUSTO 1 Trial 41,000 patients enrolled, landmark study
ESPRIT INTEGRITI TACTICS Rate of Increase in DSA
Dye strongly persistent
Presentation transcript:

Clinical Trial Results. org C. Michael Gibson, M.S., M.D. Director TIMI Data Coordinating Center Invasive Cardiologist Beth Israel Deaconess Medical Center & Chief of Clinical Research Associate Professor of Medicine, Harvard Medical School The Pathophysiology of Myocardial Perfusion

Clinical Trial Results. org Closed Muscle on Angiogram During Life Closed Muscle on Angiogram After Death Erling Falk et al. Circulation 1985; 71: Closed Muscle in Life and Death Gibson CM, 2006

Clinical Trial Results. org Pathophysiology of Downstream Microvascular Obstruction Platelet / fibrin aggregates (micro embolii) Platelet / fibrin aggregates (micro embolii) Swelling and edema of endothelial and myocardial cells Swelling and edema of endothelial and myocardial cells Neutrophil plugging Neutrophil plugging Capillary leak Capillary leak

Clinical Trial Results. org TIMI Myocardial Perfusion (TMP) Grades 6.2% 4.4% 2.0% n = 203 n = 46 n = 434 TMP Grade 3 p = 0.05 Mortality (%) n = % Gibson et al, Circulation 2000 Normal ground glass appearance of blush Dye mildly persistent at end of washout Normal ground glass appearance of blush Dye mildly persistent at end of washout Dye strongly persistent at end of washout Gone by next injection Dye strongly persistent at end of washout Gone by next injection Stain present Blush persists on next injection Stain present Blush persists on next injection No or minimal blush TMP Grade 2 TMP Grade 1 TMP Grade 0

Clinical Trial Results. org The Goal is to Restore Both Normal Epicardial & Normal Myocardial Blood Flow 3.7% n = 487 n = 328 Epicardial TIMI Grade 3 Flow Epicardial TIMI Grade 2 / 1 / 0 Flow Myocardial Perfusion Grade 3 Myocardial Perfusion Grade 3 p = % n = % n = % n = % n = way p = Mortality (%) n = % Myocardial Perfusion Grade 2 Myocardial Perfusion Grade 2 Myocardial Perfusion Grades 0/1 Myocardial Perfusion Grades 0/1 Myocardial Perfusion Grade 3 Myocardial Perfusion Grade 3 Myocardial Perfusion Grades 2/1/0 Myocardial Perfusion Grades 2/1/0 7.0% Gibson et al, Circulation 2000

Clinical Trial Results. org Myocardial Perfusion & Mortality: 8 Years of Follow-Up /1 n=236 2 n=393 3 n=148 Time (days) van ‘t Hof AWJet al. Circulation 1998; 97: Survival  Majority of patients have TIMI Grade 3 flow in epicardial artery after primary PCI However  2 of 3 pts have a cosed muscle after 0 primary PCI  Majority of patients have TIMI Grade 3 flow in epicardial artery after primary PCI However  2 of 3 pts have a cosed muscle after 0 primary PCI

Clinical Trial Results. org Two Chamber View Abn TMPG = 8 X Risk Of HE (p = 0.02) Circulation. 2006;114:

Clinical Trial Results. org MRI Hyperenhancement and Troponin Release After PCI 37% of patients had tn elevation after PCI, all had hyperenhancement on MRI 37% of patients had tn elevation after PCI, all had hyperenhancement on MRI 63% had no tn elevation and none of these pts had hyperenhancement on MRI 63% had no tn elevation and none of these pts had hyperenhancement on MRI Tn elevation was proportional to grams of MRI enhancement Tn elevation was proportional to grams of MRI enhancement Loss of myocardium was 5% of muscle mass Loss of myocardium was 5% of muscle mass Selvanayagam, Circulation. 2005;111:

Clinical Trial Results. org Early Impaired Myocardial Perfusion is Associated with Larger SPECT Infarct Size & Poorer Salvage Median = 7 p=0.004 TMPG 2/3 TMPG 0/1 n=108 n=113 Median = 13 % SPECT Infarct Size Angeja et al; Circulation 2002 In a multivariate model, TMPG 2/3 remained independently associated with a higher salvage index (p=0.001) Dibra et al, JACC 2003:41:

Clinical Trial Results. org Poorer TMPG is Associated with Higher Coronary Wedge Pressure (Pressure Distal to Stenosis) and Higher Pulmonary Capillary Wedge Pressure Coronary Wedge Pressure Closed TMPG 0/1 Closed TMPG 0/1 Open TMPG 2/3 Open TMPG 2/3 28 mm Hg 9 mm Hg K P Balachandran et al; Heart. 2004;90: p=0.001 Closed TMPG 0/1 Closed TMPG 0/1 Open TMPG 2/3 Open TMPG 2/3 p=0.02 % with PA wedge > 18 mm Hg 56% 44% Kirtane AJ et al; J Thromb Thrombolysis.2004;17:177-84

Clinical Trial Results. org Wire Passage in STEMI Can Be Associated with Staining (TMPG 1) Gibson 2004